EBLN3P and colorectal carcinoma: In this study, we also performed in vitro experiments, finding that knockdown of EBLN3P suppressed the proliferation, migration, and invasion of SW480 and HCT116 and promoted apoptosis, suggesting EBLN3P as a tumor promoter in CRC progression.